Etant l’un des premiers utilisateurs du ROTEM® sigma, il nous a accordé une interview.
With CE certification the foundation is laid for a successful market implementation of our fully automated ROTEM® sigma haemostasis analyser.
In life-threating patient care situations knowing the cause of bleed is critical. ROTEM® sigma identifies the cause of unexplained bleeding within 10 minutes.
ROTEM® sigma offers the cutting-edge combination of innovative automated functionality with accredited proven ROTEM® technology. Making it seamless and easy-to-use.
2014 Consensus conference on viscoelastic test-based transfusion guidelines for early trauma resuscitation: Report of the panel
A group of international multidisciplinary experts (including trauma surgeons; haematologists; blood bank specialists; anaesthesiologists) met 2014 in Philadelphia for a 2-day consensus conference, to discuss the use and impact of early viscoelastic-based coagulation therapy in bleeding trauma patients.
A set of nine questions as well as a two-round Delphi poll was the basis for discussions, to propose viscoelastic thresholds for triggering the specific treatment (incl. fibrinogen, platelets, plasma and prothrombin complex concentrates).
The report of the consensus group summarizing the results and recommendations of the conference was published in the Journal of Trauma and Acute Care Surgery.
J Trauma Acute Care Surg. 2015; 78: 1220-1229; Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
Do not miss live demonstrations of the new generation of devices called ROTEM® sigma during the Euroaneasthesia 2015 in Berlin. From 30th of May to 1st of June, there will be daily live performances with our experts.
We are looking forward to seeing you at the booth 85b of Tem International GmbH.
Update of Practice Guidelines for Perioperative Blood Management by the American Society of Anesthesiologist
The American Society of Anesthesiologists recently joined various professional medical
societies from the US, EU and UK by publishing updated practice guidelines for the
management of perioperative bleeding.
The newly published Practice Guidelines for Perioperative Blood Management by the American
Society of Anesthesiologist confers high levels of recommendation and evidence for the
inclusion of viscoelastic testing, as with ROTEM® for providing goal-directed therapy in
perioperative bleeding management.
Practice Guidelines for Perioperative Blood Management published in the February 2015 issue
of Anesthesiology provides updated recommendations which include the expanded use of
pharmacologic therapies, restrictive transfusion strategies and advocates for the use of goal-directed
algorithms guided by viscoelastic testing such as with thromboelastometry (ROTEM®).
The ROTEM® Hemostasis Management System has been FDA cleared since 2011 and is now
used in progressive hospitals across the US. The ROTEM® delta hemostasis analyser provides
for rapid assessment of hemostasis with 6 FDA cleared assays. Clinically significant information,
helpful in the guidance of bleeding management can be obtained and […]
ROTEM®–technology as a part of Patient Blood Management – a study of the Royal Columbian Hospital and the Vancouver General Hospital in Canada
The constant need of fresh blood products as well as a reduced number of blood donors led the Royal Columbian Hospital and the Vancouver General Hospital in Canada to an introduction of Patient Blood Management programs. In consequence of these activities both hospitals implemented ROTEM®-systems. The clinical study carried out there in the years 2012 and 2013 compares usual heart surgery and heart surgery with the use of a blood-conservation plan. Within the study, a reduction of red blood cells, platelets and plasma could be recognized with the use of ROTEM®-systems. Furthermore, the damage to kidneys from inappropriate transfusions could be reduced, money could be saved and the patients‘ health could be enhanced. The result of this study underlines the trend in the recent Patient Blood Management to use transfusions of single blood components instead of whole blood transfusions for a best possible healing process of the patient. ROTEM®-technology […]
Point of Care Coagulation Testing with ROTEM® – Case Study of the Prince Charles Hospital Brisbane Australia
Due to actual discussions on blood usage and the associated risks and costs the video on You Tube demonstrates the solution for a goal directed approach at The Prince Charles Hospital in Brisbane and their work with Patient Blood Management and ROTEM®.
This case study illustrates efforts undertaken by clinical staff at The Prince Charles Hospital in detecting, managing and monitoring critical bleeding in cardiac surgery patients through the use of Point of Care Coagulation Testing with ROTEM®.
NICE has assessed viscoelastometric point-of-care testing devices, to help the NHS (National Health Service) to decide whether the use of these products is clinically and cost-effective.
Viscoelastometric point-of-care testing may be useful to help determine if bleeding is based on a reduced blood’s ability to clot or due to surgical reasons. This helps the doctor choosing the right treatment to stop bleeding. Using these systems may mean that patients are less likely to be transfused during and after surgery and to have to undergo revision surgery due to ongoing bleeding.
NICE has recommended viscoelastic testing devices – the ROTEM® system from Tem International GmbH – to help detect and manage life-threating bleeding in patients during and after cardiac surgery.
The NICE’s Health Technologies Adoption program works together with NHS centers to gain and share their experiences in using viscoelastometric point-of-care testing devices with other centers which may want to start using one […]
Tem International GmbH provides the new ROTEM® platelet module as from November 2013.
The ROTEM® platelet measures platelet aggregation in whole blood samples using impedance aggregometry.
The new device is run in conjunction with the ROTEM® delta, and is compatible with all existing ROTEM® delta models with serial numbers > 2000.
The ROTEM® platelet supplements the platelet function analysis in the ROTEM® – guided peri-operative bleeding management.
The current issue focusses on the topic European guidelines for severe bleeding management.
In this newsletter we highlight recommendations of recently published European guidelines
for severe bleeding management dealing with the use of viscoelastic testing and goal-directed
therapy in clinical settings.
The current issue focusses on the topic trauma.
Besides an interview with Dr. Herbert Schöchl, anesthetist and intensivist from Salzburg (Austria), we present an interesting case report in the section “Interpretation Guide” for you. A current recommended reading from the Scandinavian Journal of Trauma, entitled “Early and individualized goal-directed therapy for trauma-induced coagulopathy” is pointed out.
In this and the coming newsletters, specific topics will be discussed.
The current issue focusses on the topic post-partum haemorrhage.
Besides an interesting interview with Dr. Alexander Hanke, anesthesiologist and intensivist from Hannover Medical School (Germany), we provide an interesting case study in the section “Interpretation Guide” for you.
For the full ROTEM® News click here.
Munich, Germany (23. September 2012):
The Canadian regulatory authority Health Canada has licensed the sale of the ROTEM® delta hemostasis analyzer system of Tem Innovations GmbH in Canada. Therefore another global market can benefit from the ROTEM® delta system as an ideal analysis tool for rapid and effective blood management. The ROTEM® delta unit with its unique five assays (in-tem®, ex-tem®, hep-tem®, fib-tem® and ap-tem®) provides detailed hemostasis information to physicians in cardiac and vascular surgery, tumor resection or transplantation, orthopedic surgery, trauma care and obstetrics. With more detailed hemostasis information at the clinician’s disposal, patient outcomes have been shown to improve and hospital expenses related to blood products decrease.
Besides an exciting interview about the implementation of a ROTEM® system in the clinical practice with Dr. Lynne Anderson, we provide new practical interpretation cases for you.
In the column “frequently asked question of the month” the customer service explains the data export from the database.
A recent prospective randomized study of the university hospital Frankfurt am Main on “Point-of-Care Testing” will be presented in the literature section.
Moreover, we inform you about the upcoming international conferences and events.
It is with great pleasure to announce that Tem International GmbH will initiate a ROTEM® Expert Meeting for the Asian- Pacific Region in 2012.
The meeting is based on the idea that leading ROTEM®-Experts from Europe share their knowledge gained over many years now with ROTEM® users or opinion leaders from countries of the Asian-Pacific-Region. Lectures and workshops will be based on peri-operative coagulation management in the field of cardiac surgery, liver transplantation, trauma, obstetric, orthopaedic and visceral surgery.
The meeting will take place in Bangkok, October, 25th to 26th 2012.
European as well as Asian anaesthetists will chair the meeting.
We look forward to welcoming many ROTEM® users and opinion leaders in Bangkok for an interesting and successful meeting.
Dr. Thomas Ebinger (CEO), Dr. Klaus Görlinger (Clinical Director) and Elfriede Steffan (Manager Commercial Development)
Munich, Germany (April 26, 2012):
Dr. Klaus Görlinger has been appointed new clinical director at Tem International GmbH in Munich as of 1st of July 2012.
“Increasing challenges in the development and additional requirements worldwide as a consequence of the FDA approval last year, require the reinforcement of new employees. Induced by the expanded collaboration with Dr. Görlinger we succeeded to strengthen our team with a very highly qualified and experienced clinical director”
said Dr. Thomas Ebinger, CEO of Tem International GmbH.
Prof. Karim Brohi – trauma surgeon at the Royal London Hospital – is interviewed on the best strategies for acute bleeding management.
This documentary (mostly in Dutch language) was screened on the 11th April 2012 on NTR-VPRO – and can also be seen online on: http://www.wetenschap24.nl/programmas/labyrint/labyrint-tv.html